Director, US Health Economic Value Access (HEVA)

Nice to have:

Doctorate degree (PharmD, MD, DO or PhD) preferred.

Cell therapy, Hematology/Oncology experience preferred.

The physical demands described here represent those that an employee must meet to perform the essential functions of this job successfully. Reasonable accommodation may be made upon request to enable individuals to perform essential functions. Please contact Human Resources to request accommodation.

$230,000

—

$260,000 USD

The statements contained in this document are intended to describe the general nature and level of work being performed by a colleague assigned to this description. They are not intended to constitute a comprehensive list of functions, duties, or local variances. Management retains the discretion to add or to change the duties of the position at any time.

Iovance is committed to cultivating and offering a diverse and inclusive work environment. As an equal-opportunity employer, our employees and applicants will be considered without regard to an individual’s race, color, religion, sex, pregnancy, national origin, age, physical and mental disability, marital status, sexual orientation, gender identity, gender expression, genetic information, military and veteran status, and any other characteristic protected by applicable law. If you need assistance or accommodation to apply to one of our opportunities, please contact

careers@iovance.com

Partner with Policy and Payer Marketing on engagement strategy with external partners and formulary decision-makers primarily in national/regional health plans, CMS, integrated delivery networks (IDNs), ATCs, Large physician groups (LPGs).

Build and drive the US value proposition story for AMTAGVI and pipeline therapies to include but not limited to impact of complete and partial responses on PROs, productivity and future treatment costs and pharmacoeconomic impact of evolving treatment patterns.

Incorporate health economics, business analytics and competitive intelligence into the development of innovative strategies to gain, improve and defend public and private market access, specifically, pricing (and contracting) strategic planning within Market Access to create innovative proposals to meet public and private payer needs.

Lead development and maintenance of formulary submission packages, total cost of care US models and other economic modeling and healthcare resource use analyses.

Support field-based cross-functional teams to provide pharmacoeconomic expertise in access engagements.

Compliantly manage operations of Iovance Pricing Committee, GTN implications review and update charter and plan agendas to drive development of Committee recommendations.